Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 518

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

1043	$PMCB News Article - PharmaCyte Biotech Releases	whytestocks	06/25/2019 9:30:42 AM
1042	Worldwide Pain Management Devices Market Research	marketindustryreport	06/20/2019 6:24:36 AM
1041	Market Industry Reports (MIR) has published a new	marketindustryreport	06/18/2019 8:18:30 AM
1040	Market Industry Reports (MIR) has published a new	marketindustryreport	06/10/2019 5:56:38 AM
1039	The global Disposable Syrin	marketindustryreport	06/06/2019 6:14:45 AM
1038	The next generati	dorotheapiper	05/30/2019 2:17:53 AM
1037	$PMCB < $0.051 znewcar (1)	PoemStone	02/04/2019 6:20:55 PM
1036	38.10% v14,192,781 c.058000 f1,126,904,510	znewcar1	02/04/2019 5:37:42 PM
1035	$PMCB call it	PoemStone	08/04/2018 12:13:19 PM
1034	$PMCB PharmaCyte Biotech Files Patent	Lets Roll	03/27/2018 9:42:13 AM
1033	$PMCB Increasing prevalence of cancer and rise in	trooperstocks	03/27/2018 8:42:25 AM
1032	$PMCB on alert! Take a look at the company	Lets Roll	03/22/2018 9:36:45 AM
1031	Check out the talented and experienced management	Lets Roll	03/21/2018 11:05:35 AM
1030	The daily chart does look ready for the next leg	Lets Roll	03/21/2018 10:02:39 AM
1029	http://pharmabypharmd.com/amicus-therapeutics-kno	Hiooletsgobio	02/07/2018 11:59:25 PM
1028	What is most interesting to me about the S-3 is	Triple9	09/16/2017 12:47:01 PM
1027	$PMCB has medical and scientific professionals	Triple9	09/14/2017 5:22:57 PM
1026	Pepper Hamilton LLP, one of the oldest law firms	Triple9	09/14/2017 5:21:44 PM
1025	Work on the master cell line started on June 5,	Triple9	09/14/2017 5:21:08 PM
1024	OK, we have the Imperial Room at the Fairmont	Triple9	07/21/2017 9:10:35 AM
1023	$PMCB great reading/ $PMCB PharmaCyte Biotech	mick	05/14/2017 10:42:31 AM
1022	THE WINNERS ARE $PMCB	mick	04/24/2017 10:42:13 AM
1021	$pmcb is stronger today than ever with	mick	04/19/2017 11:46:49 PM
1020	$PMCB / great read, dd, update	mick	04/19/2017 11:44:46 PM
1019	LAGUNA HILLS, Calif., April 18, 2017 (GLOBE (1)	mick	04/19/2017 4:36:27 PM
1018	LAGUNA HILLS, Calif., April 19, 2017 (GLOBE	mick	04/19/2017 4:25:24 PM
1017	PharmaCyte Biotech Receives the 2017 Pipelines	Triple9	04/19/2017 9:32:36 AM
1016	$PMCB	mick	04/17/2017 7:18:02 PM
1015	$PMCB voting 2393 / PharmaCyte Biotech PharmaCyte	mick	04/12/2017 10:21:44 AM
1014	$PMCB , GOOD MORNING	mick	04/12/2017 10:21:31 AM
1013	PharmaCyte Biotechs Cannabis Research Program	Triple9	04/10/2017 11:11:29 AM
1012	www.stockta.com/cgi-bin/candle.pl?cobrand=&symb=PM	mick	04/07/2017 4:48:45 PM
1011	$PMCB	mick	04/07/2017 4:45:24 PM
1010	$PMCB	mick	04/07/2017 3:19:17 PM
1009	$PMCB ON VOTING $PMCB 943	mick	04/07/2017 12:14:07 PM
1008	$PMCB VOTE FOR FAVORITE BIOTECH COMPANY $PMCB	mick	04/05/2017 4:41:59 PM
1007	$PMCB did ya vote ?????	mick	04/05/2017 4:39:09 PM
1006	$PMCB DID YOU VOTE ?????	mick	04/05/2017 4:38:14 PM
1005	PharmaCyte Biotech Appoints Dr. Mark Rabe	Triple9	04/03/2017 9:26:39 AM
1004	$PMCB News! First Ever Cannabis-Based ETF to	mick	03/25/2017 7:20:33 PM
1003	$PMCB PharmaCyte Biotech is currently developing	mick	03/25/2017 7:19:28 PM
1002	$PMCB Part 1 PharmaCyte Biotech Medical &	mick	03/25/2017 7:18:30 PM
1001	$PMCB Part 2 PharmaCyte Biotech Medical &	mick	03/25/2017 7:17:55 PM
1000	$PMCB Part 3 PharmaCyte Biotech Medical &	mick	03/25/2017 7:17:21 PM
999	$PMCB Part 4 PharmaCyte Biotech Medical &	mick	03/25/2017 7:16:46 PM
998	$PMCB Part 5 PharmaCyte Biotech Medical &	mick	03/25/2017 7:16:04 PM
997	Pharmacyte Biotech Inc Has A Fast Track To	Triple9	03/19/2017 10:56:02 PM
996	Why $PMCB getting the IND just right is so	Triple9	03/19/2017 11:48:37 AM
995	Is An FDA Pre-IND Meeting Worth It? How To Decide	Triple9	03/17/2017 10:09:35 AM
994	PharmaCyte Biotech CEO Addresses IND Submission	Triple9	03/17/2017 9:02:22 AM

Newer

Older

Recent Articles

• Global Efforts Intensify for a Comprehensive Plastics Treaty
• NOVONIX Secures Major Offtake Agreement with PowerCo for Graphite Supply
• Emerging Markets Face Challenges Amid US Economic Dominance
• Investigation into Quanterix Corporation Securities Claims
• Paragon 28, Inc. Investors Invited to Join Class Action Against Company
• Sunlight Financial Holdings Faces Class Action Lawsuit Risks
• Bumble Inc. Faces Class Action: Key Insights for Investors
• Investors Urged to Join ASML Class Action for Recovery
• Analyst Forecasts Bitcoin Growth: Could Hit $180K and Over $1M
• How a Coffee Meeting Saved Amazon's Future with Costco Insight
• Bitget Introduces Pioneering VND Transfers Through VietQR
• Bitcoin Outlook for 2024: Aiming for $125,000
• Hezbollah's Response to Recent Israeli Attacks Sparks Conflict
• Mark Cuban Shares His Secrets to Negotiation Mastery
• Elon Musk's Wealth Surges to Incredible Heights in 2024
• Expert Analyst Cautions on Bitcoin as Market Shows Signs of Volatility
• How Political Climate Shapes Home Buying Sentiments Today
• WM Technology Investors Urged to Act Before Critical Deadline
• Shiba Inu's Promising Rise: Analyst Predicts 2,000% Gains
• American Support Grows for Trump’s Second-Term Vision
• Opportunity for Acadia Healthcare Investors to Lead Class Action
• Elon Musk's Social Media Criticism Affects Federal Civil Servants
• Investors Alert: Winnebago Industries Faces Serious Concerns
• Tragic Murder of Rabbi Shakes Community and Diplomacy Efforts
• Mary Trump's Concerns Over Donald Trump's Ties to Putin
• Former BP Executive Bernard Looney Takes Helm at Prometheus Hyperscale
• Swiss Referendum Results Reflect Concerns Over Tenant Rights
• Visa Inc. Faces Class Action Lawsuit: Key Details for Investors
• Larry Page's Unexpected Legacy Choice: A Future with Musk
• Election Workers Seek Contempt Against Giuliani for Defamation
• Warren Buffett's Bold $550 Million Bet on Opportunities Ahead
• Israel Market Update: TA 35 Sees Notable Gains as Stocks Rise
• Blockbuster Weekend: 'Wicked' Achieves Impressive Box Office Success
• Litecoin Experiences Significant Decline Amid Market Trends
• Kiyosaki Anticipates Trump's Role as Crypto Advocate in America
• Legal Advisory for Hasbro Investors Amid Class Action Suit
• Exploring TON Society's Vision for Community Consensus and Growth
• Top Mid-Cap Stocks to Watch: Applied Digital and Hims & Hers
• Apple's Antitrust Setback: CCI Denies Request to Halt Investigation
• Understanding Recent Stock Performance: Top Large-Cap Losers This Week
• Brazilian Meat Suppliers Halt Deliveries Amid Carrefour Controversy
• Understanding Immigration Policy's Impact on Rideshare Services
• Elon Musk's Take on Jim Cramer's Bitcoin Influence
• TMC Metals Company Class Action: What Investors Should Know
• Housing Market Struggles: Experts Urge Price Cuts to Engage Buyers
• Top Large-Cap Stocks That Sparked Growth Last Week
• Bitcoin Open Interest Hits $70 Billion: A Milestone Moment
• Burlington Stores vs. Kohl’s: A Stock Buy and Sell Update
• U.S. Telecoms Rally Against Escalating Chinese Cyber Threats
• Understanding Your Rights: IMX Token Investors Should Act